GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company. Their product offering include vaccines, speciality medicines & general medicines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases.
GlaxoSmithKline Pharmaceuticals CMP is 1390.95. Negative aspects of the company are high valuation (P.E = 38.6), declining annual net profit & MFs are decreasing stake. Positive aspects of the company are improving cash from operations, no debt & zero promoter pledge.
Entry after closing above 1402. Targets in the stock will be 1435 & 1461. Long term target in the stock will be 1489. Stop loss in the stock should be maintained at closing below 1288.
GlaxoSmithKline Pharmaceuticals CMP is 1390.95. Negative aspects of the company are high valuation (P.E = 38.6), declining annual net profit & MFs are decreasing stake. Positive aspects of the company are improving cash from operations, no debt & zero promoter pledge.
Entry after closing above 1402. Targets in the stock will be 1435 & 1461. Long term target in the stock will be 1489. Stop loss in the stock should be maintained at closing below 1288.
Happy Candles Investment